The HinduLean L·
Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
Read at The Hindu →
Business · 1 sources covering this
Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue
Lower sales of cancer drug lenalidomide and ₹239.7 crore provision post recent quality issue around Semaglutide impact revenue of generic drugmaker
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/b6636a52c7f3f520338052c9c2192fb15c1941da" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Dr. Reddy’s Q1 net plunges 69% to ₹435.6 cr on lower revenue"></iframe>
